Correlation Between Passage Bio and ViaSat
Can any of the company-specific risk be diversified away by investing in both Passage Bio and ViaSat at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Passage Bio and ViaSat into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Passage Bio and ViaSat Inc, you can compare the effects of market volatilities on Passage Bio and ViaSat and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Passage Bio with a short position of ViaSat. Check out your portfolio center. Please also check ongoing floating volatility patterns of Passage Bio and ViaSat.
Diversification Opportunities for Passage Bio and ViaSat
0.06 | Correlation Coefficient |
Significant diversification
The 3 months correlation between Passage and ViaSat is 0.06. Overlapping area represents the amount of risk that can be diversified away by holding Passage Bio and ViaSat Inc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on ViaSat Inc and Passage Bio is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Passage Bio are associated (or correlated) with ViaSat. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of ViaSat Inc has no effect on the direction of Passage Bio i.e., Passage Bio and ViaSat go up and down completely randomly.
Pair Corralation between Passage Bio and ViaSat
Given the investment horizon of 90 days Passage Bio is expected to under-perform the ViaSat. In addition to that, Passage Bio is 1.53 times more volatile than ViaSat Inc. It trades about -0.32 of its total potential returns per unit of risk. ViaSat Inc is currently generating about -0.14 per unit of volatility. If you would invest 1,006 in ViaSat Inc on October 1, 2024 and sell it today you would lose (112.00) from holding ViaSat Inc or give up 11.13% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Insignificant |
Accuracy | 95.24% |
Values | Daily Returns |
Passage Bio vs. ViaSat Inc
Performance |
Timeline |
Passage Bio |
ViaSat Inc |
Passage Bio and ViaSat Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Passage Bio and ViaSat
The main advantage of trading using opposite Passage Bio and ViaSat positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Passage Bio position performs unexpectedly, ViaSat can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ViaSat will offset losses from the drop in ViaSat's long position.Passage Bio vs. Black Diamond Therapeutics | Passage Bio vs. Revolution Medicines | Passage Bio vs. Stoke Therapeutics | Passage Bio vs. Cabaletta Bio |
ViaSat vs. Comtech Telecommunications Corp | ViaSat vs. NETGEAR | ViaSat vs. KVH Industries | ViaSat vs. Silicom |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.
Other Complementary Tools
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
Fundamental Analysis View fundamental data based on most recent published financial statements | |
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
Portfolio Anywhere Track or share privately all of your investments from the convenience of any device |